Marsannay le Bois, France

Laurent Mounier

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Laurent Mounier

Introduction

Laurent Mounier is a distinguished inventor based in Marsannay le Bois, France. With a focus on advancing medical treatments, he holds a patent that contributes significantly to the field of immunology. His work reflects the importance of innovation in developing compounds that target specific conditions.

Latest Patents

Mounier's notable patent involves Nuclear receptor modulators, which provides a comprehensive description of compounds with a generalized Formula (I) along with their pharmaceutically acceptable salts. This invention is poised to play a crucial role in treating various immunological conditions, showcasing Mounier's dedication to addressing pressing health issues through scientific discovery.

Career Highlights

Throughout his career, Laurent Mounier has contributed significantly to the pharmaceutical industry, particularly through his role at AbbVie Inc., a leading company renowned for its commitment to innovative therapies. His work is a testament to the strong focus on research and development within the organization, fostering a culture of innovation that benefits patients worldwide.

Collaborations

Mounier has collaborated with notable colleagues, including Maria A. Argiriadi and Eric C. Breinlinger, bringing together diverse expertise to enhance their research efforts. These collaborations highlight the value of teamwork in the realm of scientific innovation, as multiple perspectives often lead to groundbreaking solutions.

Conclusion

Inventor Laurent Mounier exemplifies the spirit of innovation through his significant contributions to the field of immunology. His patent on Nuclear receptor modulators not only showcases his inventiveness but also underscores the impact of collaboration in advancing medical science. As he continues his work at AbbVie Inc., Mounier remains a key figure driving forward the boundaries of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…